Webinar - 7 October 2024
Advanced Diagnostic testing
A continuity of care
Where some genetic testing companies require patients to go elsewhere for diagnostic testing, Labcorp offers continuity of care When you and your patient need diagnostic testing, either for routine prenatal diagnosis, confirmation of NIPS (NIPT) results, pregnancy loss, follow-up of a high-risk pregnancy, or diagnostic testing of a fetus or neonate when an inherited genetic disorder is suspected, we can help.
A wide range of tests
With a wide range of diagnostic tests— including chromosome analysis, SNP microarray and whole exome sequencing on multiple sample types — we deliver insights for every stage: fetal, pediatric, and adult.
Labcorp SNP microarray has applications for pediatric (cord blood, peripheral blood, and buccal swab), prenatal (amniotic fluid and chorionic villus), and POC (fresh tissue and formalin-fixed paraffin-embedded) sample types.
Prenatal chromosome analysis is also available. ACOG also recommends that all pregnant women should be offered prenatal assessment for aneuploidy by screening or diagnostic testing regardless of maternal age or other risk factors.1
For patients with multiple or overlapping symptoms that cannot be clearly linked to a single diagnosis, whole exome sequencing is available. Applications for trio, duo or proband are available, and both blood and buccal swab sample types are accepted.
Additional diagnostic testing options
Fabry Disease Enzyme Analysis
(alpha-galactosidase-A)
Fabry disease is an X-linked disorder of glycosphingolipid catabolism caused by deficient activity of the lysosomal enzyme, α-galactosidase A (GLA). Signs and symptoms include angiokeratomas, ocular opacities, painful neuropathy in the extremities, progressive renal insufficiency and cardiac hypertrophy.
Learn more about Fabry Disease Enzyme Analysis
(alpha-galactosidase-A)
GeneSeq
Cardio Profiles
Familial cardiac diseases are associated with up to 80% of cases of sudden cardiac death in young patients.1 Identification of individuals with pathogenic mutations in genes associated with cardiac disease may allow timely initiation of screening and treatment that may help prevent myocardial infarction, stroke, and sudden cardiac death. These tests are available for order through Labcorp.
Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder that causes abnormal development of blood vessels and is present in approximately one in 8,000 people.2 It affects males and females from all racial and ethnic groups. The disorder is also referred to as Osler-Weber-Rendu (OWR) syndrome. These tests are available for order through Labcorp.
Microdeletion Analysis (FISH)
Available microdeletion analyses include: Angelman syndrome, cri-du-chat, DiGeorge/Velocardiofacial syndromes, Kallman syndrome, Miller-Dieker syndrome, Prader-Willi syndrome, Smith-Magenis syndrome, steroid sulfatase deficiency (X-linked ichthyosis), Williams syndrome, Wolf-Hirschhorn syndrome.
Pompe Disease Enzyme Test
Pompe disease is an inborn error of glycogen metabolism due to a deficiency of acid alpha-glucosidase. In the infantile form, clinical symptoms include hypotonia, failure to thrive, and progressive hypertrophic cardiomyopathy. The late-onset form can present from childhood through adulthood with progressive muscle weakness and respiratory dysfunction.
Prenatal Noonan Syndrome
Prenatal diagnosis for at-risk pregnancies when a parent is affected or when abnormalities are seen on fetal ultrasound. Noonan syndrome and Noonan-like syndromes tend to be predominantly associated with different genes or different variants within the same genes.
Y Chromosome Microdeletion Analysis
Detects microdeletions in three azoospermia factor chromosome regions (Yq11.23) that contain genes with a role in spermatogenesis.
Zygosity Testing
Zygosity testing determines if the fetuses in a multiple gestation are identical or fraternal . Zygosity testing might be desired in cases when ultrasound identifies a discordance between fetuses in a multiple gestation.
Pregnancy loss
Labcorp offers a portfolio of tests to help with differential diagnosis of pregnancy loss and recurrent pregnancy loss (RPL). Differentiating sporadic miscarriages from RPL can be difficult. However, there is guidance from the American Society for Reproductive Medicine (ASRM) on suspected causes, clinical evaluation and patient management. For more information on our comprehensive offering, read the full Recurrent Pregnancy Loss educational newsletter or click the links below.
Reveal® SNP Microarray
POC
Detects chromosomal imbalances related to fetal loss. Can be performed directly on POC tissue without having to grow cells, optimizing success rate and turnaround time.
Reveal® SNP Microarray
POC (FFPE)
Ability to analyze formalin fixed paraffin-embedded samples enabling a provider to order a SNP microarray on a patient’s previous pregnancy loss
Cytogenetics blood chromosome analysis
Indications for cytogenetic analysis on blood include: infertility and multiple pregnancy loss; and family history of chromosome abnormality, ultrasound abnormalities or family history of chromosome abnormality.
Thrombophilia testing
These tests and profiles cover the most commonly ordered laboratory tests assessing the inherited and acquired risks of thrombosis potentially associated with thrombophilia in pregnant women with and without a history of previous thrombosis.
Watch
Genetic Counseling Webinar
Webinar - 2 July 2024
Carrier screening: Providing valuable insights for you and your patients
Webinar - 11 January 2024
Genetic Counseling: Supporting the provider and patient through the rare disease diagnostic journey
Additional Resources
Understanding Costs
Use our cost estimator get an immediate estimate for most tests we offer based on your specific insurance plan (so have your policy number handy).
Understand Your Results
If you have already had a test, we can answer questions about your results.
Genetic Counseling
Genetic counselors translate and communicate genetic information into practical, understandable terms.
References:
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders. Obstet Gynecol. 2016;127(5):e108-e122. doi:10.1097/AOG.00000000000014051.
- Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet. 2006;43(2):97-110. doi:10.1136/jmg.2005.030833